Tag: arteriovenous malformation

Odanacatib for the Treatment of Postmenopausal Osteoporosis: Results of the LOFT Multicentre, Randomised, Double-Blind, Placebo-Controlled Trial and LOFT Extension Study 1. The cathepsin K inhibitor odanacatib reduced the risk of fracture but was associated with significantly increased risk of cardiovascular events, specifically stroke, in postmenopausal women with osteoporosis compared to...
1. There was no difference between elderly patients (≥60 years) and non-elderly patients in the occurrence of adverse outcomes following radiosurgery for arteriovenous malformation. 2. Elderly age was not predictive of arteriovenous malformation obliteration, radiation-induced changes or hemorrhage following radiosurgery. Evidence Rating Level: 2 (Good) Study Rundown: Cerebral arteriovenous malformation (AVM) is uncommon...